A61P 11 - Drugs for disorders of the respiratory system

Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2004
12/29/2004	CN1557381A Sore throat relieving preparation
12/29/2004	CN1557336A Cardiovascular and respiratory function regulating biological active prescription
12/29/2004	CN1557311A Fibrauretine capsule tablet and its preparation method
12/29/2004	CN1557308A Tiotropium aerosol inhalant and its preparation method
12/29/2004	CN1557293A Brufen arginine pseudoephedrine hydrochloride compound formulation
12/29/2004	CN1557285A Bromhexine Hydrochloride aseptic freeze-drying formulation for injection and its preparation method
12/29/2004	CN1557284A Biological spray for snoring relieve
12/29/2004	CN1557234A Cigarette for nasal health and its making method
12/29/2004	CN1182134C Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for treatment of pain
12/29/2004	CN1182129C Benzopyran derivatives having leukotriene-antagonistic action
12/29/2004	CN1181888C Stable recombination human alpha interferon liquid preparation and productive process thereof
12/29/2004	CN1181886C Application of TNF-derived peptides in the treatment of oedema
12/29/2004	CN1181880C Compound macrostem onion preparation for treating chronic obstructive pulmonary disease and its preparing method
12/29/2004	CN1181872C Medicine for treating acute pulmonary infection disease and its preparing method
12/29/2004	CN1181846C Traditional Chinese medicine for treating child pneumonia
12/29/2004	CA2529565A1 Modified bordetella adenylate cyclase comprising or lacking cd11b/cd18 interaction domain and uses thereof
12/29/2004	CA2528711A1 Pharmaceutical compositions including an antihistamine and a stimulant and use thereof
12/29/2004	CA2524700A1 N-substituted 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators
12/28/2004	US6835846 Aliphatic compounds, process for their preparation and their usage
12/28/2004	US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis
12/28/2004	US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004	US6835751 Bicyclic amino acids as pharmaceutical agents
12/28/2004	US6835740 Methods for treating sleep apnea and sleep induced apnea using optically pure (+) norcisapride
12/28/2004	US6835738 Phenylalanine enamide derivatives
12/28/2004	US6835737 Quinoline inhibitors of cGMP phosphodiesterase
12/28/2004	US6835734 1,3-dioxolanes with antitussive activity
12/28/2004	US6835732 Modulation of the adenosine A2A receptor; cardioprotective agents; antiischemic agents; antihypoxia agents; central nervous system disorders, Alzheimer's disease, Parkinson's disease, anxiolytic agents; antidepressants; analgesics
12/28/2004	US6835731 Chemokine receptor binding heterocyclic compounds
12/28/2004	US6835716 Bactericides, antiprotozoa agents
12/28/2004	US6835714 Heterocyclic compounds, intermediates thereof and elastase inhibitors
12/28/2004	US6835711 Use of poly-Glu,Tyr for neuroprotective therapy
12/28/2004	US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery
12/28/2004	CA2226039C Pyridylfuran and pyridylthiophene compounds
12/23/2004	WO2004111052A1 Pyrrolopyrimidine derivatives as modulators of multi-drug resistance (mdr)
12/23/2004	WO2004111038A1 5,6-bis (4-chlorophenyl)-n-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide
12/23/2004	WO2004111037A1 Cyclic tertiary amine compound
12/23/2004	WO2004111033A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
12/23/2004	WO2004111027A1 The isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as the effective constituents
12/23/2004	WO2004110988A1 Protease inhibitors
12/23/2004	WO2004110986A1 Benzamide derivative or salt thereof
12/23/2004	WO2004110552A1 Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
12/23/2004	WO2004110491A1 Combined doses
12/23/2004	WO2004110463A1 Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
12/23/2004	WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
12/23/2004	WO2004110450A1 Composition comprising a pulmonary surfactant and a pde5 inhibitor for the treatment of lung diseases
12/23/2004	WO2004110426A1 Modulation of airway inflammation in patients with cystic fibrosis and related diseases
12/23/2004	WO2004110415A2 Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments
12/23/2004	WO2004110404A1 Combined doses of tiotropium and fluticasone
12/23/2004	WO2004110401A2 Inhalation antiviral patch
12/23/2004	WO2004110392A2 Compositions and methods for treating coronavirus infection and sars
12/23/2004	WO2004110379A2 A1 adenosine receptor antagonists
12/23/2004	WO2004110344A2 New azetidine compounds
12/23/2004	WO2004093852A3 Use of steroid derivatives for the treatment of angiotensin ii related disease e.g. cardiovascular and proliferative disorders
12/23/2004	US20040260096 Novel substituted 4-phenyl-4-{1h-imidazol-2-yl}-piperidine derivatives and their use as selective non-peptide delta opioid agonists
12/23/2004	US20040259952 Formulations for oral administration of cromolyn sodium
12/23/2004	US20040259935 Novel antiallergens ond prevention of allergenic diseases using polylactic acid to combat rhinitis
12/23/2004	US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004	US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/23/2004	US20040259927 Compounds for treatment of sleep apnea, respiratory system disorders or kidney failure
12/23/2004	US20040259912 N-(4-benzhydryloxy-3-isobutyrylphenyl)-N'-(3,4-dimethoxyphenyl)urea for example; vanilloid receptor agonists; use as analgesic and or for treating urinary frequency and/or urinary incontinence
12/23/2004	US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes
12/23/2004	US20040259893 Use of tyrosine kinase inhibitions for treating allergic diseases
12/23/2004	US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example
12/23/2004	US20040259889 Vasconstriction ; administering adenosine receptor antagonist
12/23/2004	US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents
12/23/2004	US20040259865 Laxative; adenosine receptor antagonist
12/23/2004	US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof
12/23/2004	US20040259842 Anticoagulants ; antiischemic agents; autoimmune disease; antihistamines; antiallergens; antihistamines; brain disorders; kidney disease; pancreatitis; Alzheimer's disease
12/23/2004	US20040259809 Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof
12/23/2004	US20040259781 Drug screening ; polypeptide interfers with binding of fibronectin to; anticancer agents; antihistamines, antiarthritic agents, autoimmune disease, wound healing agents
12/23/2004	US20040259201 Recombinant surfactant protein D compositions and methods of use thereof
12/23/2004	US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies
12/23/2004	US20040258624 Combined doses
12/23/2004	CA2529127A1 Combined doses of tiotropium and fluticasone
12/23/2004	CA2528929A1 Cyclic tertiary amine compound
12/23/2004	CA2528863A1 Combined doses
12/23/2004	CA2528367A1 A1 adenosine receptor antagonists
12/23/2004	CA2527856A1 Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments
12/23/2004	CA2527033A1 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	CA2526387A1 Benzamide derivative or salt thereof
12/23/2004	CA2520148A1 Compositions and methods for treating coronavirus infection and sars
12/22/2004	EP1489185A1 Methods and compositions for use in splicesome mediated rna trans-splicing
12/22/2004	EP1489092A1 Modified Bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof
12/22/2004	EP1489090A1 Novel pseudoerythormycin derivatives
12/22/2004	EP1489083A1 Fused bicyclic pyridine derivative as tachykinin receptor antagonist
12/22/2004	EP1489081A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
12/22/2004	EP1489071A1 N-substituted, 3,4-dihydro-1H-isoquinoline as potassium channels modulators
12/22/2004	EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders
12/22/2004	EP1488795A1 Remedies for lung cancer
12/22/2004	EP1487968A1 Methods of inducing differentiation of stem cells into a specific cell lineage
12/22/2004	EP1487865A2 USES OF MAMMALIAN CYTOKINEi; RELATED REAGENTS
12/22/2004	EP1487842A1 An optically acitve pyridine derivative and a medicament containing the same
12/22/2004	EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/22/2004	EP1487832A1 Micronized crystalline tiotropium bromide
12/22/2004	EP1487831A1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs
12/22/2004	EP1487828A2 Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487821A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
12/22/2004	EP1487817A1 Piperidine derivatives useful as modulators of chemokine receptor activity

1 ... 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 ... 878